A systematic bi-genomic split-GFP assay illuminates the mitochondrial matrix proteome and protein targeting routes

  1. Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel
  2. Université de Strasbourg, CNRS, Génétique Moléculaire, Génomique, Microbiologie, UMR7156, 67084 Strasbourg Cedex, France
  3. Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warszawa, Poland

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Agnieszka Chacinska
    IMol Polish Academy of Sciences, Warsaw, Poland
  • Senior Editor
    Felix Campelo
    Institute of Photonic Sciences, Barcelona, Spain

Reviewer #1 (Public Review):

Summary:

The study conducted by the Shouldiner's group advances the understanding of mitochondrial biology through the utilization of their bi-genomic (BiG) split-GFP assay, which they had previously developed and reported. This research endeavors to consolidate the catalog of matrix and inner membrane mitochondrial proteins. In their approach, a genetic framework was employed wherein a GFP fragment (GFP1-10) is encoded within the mitochondrial genome. Subsequently, a collection of strains was created, with each strain expressing a distinct protein tagged with the GFP11 fragment. The reconstitution of GFP fluorescence occurs upon the import of the protein under examination into the mitochondria.

Strengths:

Notably, this assay was executed under six distinct conditions, facilitating the visualization of approximately 400 mitochondrial proteins. Remarkably, 50 proteins were conclusively assigned to mitochondria for the first time through this methodology. The strains developed and the extensive dataset generated in this study serve as a valuable resource for the comprehensive study of mitochondrial biology. Specifically, it provides a list of 50 "eclipsed" proteins whose role in mitochondria remains to be characterized.

Weaknesses:

The work could include some functional studies of at least one of the newly identified 50 proteins.

Reviewer #2 (Public Review):

The authors addressed the question of how mitochondrial proteins that are dually localized or only to a minor fraction localized to mitochondria can be visualized on the whole genome scale. For this, they used an established and previously published method called BiG split-GFP, in which GFP strands 1-10 are encoded in the mitochondrial DNA and fused the GFP11 strand C-terminally to the yeast ORFs using the C-SWAT library. The generated library was imaged under different growth and stress conditions and yielded positive mitochondrial localization for approximately 400 proteins. The strength of this method is the detection of proteins that are dually localized with only a minor fraction within mitochondria, which so far has hampered their visualization due to strong fluorescent signals from other cellular localizations. The weakness of this method is that due to the localization of the GFP1-10 in the mitochondrial matrix, only matrix proteins and IM proteins with their C-termini facing the matrix can be detected. Also, proteins that are assembled into multimeric complexes (which will be the case for probably a high number of matrix and inner membrane-localized proteins) resulting in the C-terminal GFP11 being buried are likely not detected as positive hits in this approach. Taking these limitations into consideration, the authors provide a new library that can help in the identification of eclipsed protein distribution within mitochondria, thus further increasing our knowledge of the complete mitochondrial proteome. The approach of global tagging of the yeast genome is the logical consequence after the successful establishment of the BiG split-GFP for mitochondria. The authors also propose that their approach can be applied to investigate the topology of inner membrane proteins, however, for this, the inherent issue remains that it cannot be excluded that even the small GFP11 tag can impact on protein biogenesis and topology. Thus, the approach will not overcome the need to assess protein topology analysis via biochemical approaches on endogenous untagged proteins.

Reviewer #3 (Public Review):

Summary:

Here, Bykov et al move the bi-genomic split-GFP system they previously established to the genome-wide level in order to obtain a more comprehensive list of mitochondrial matrix and inner membrane proteins. In this very elegant split-GFP system, the longer GFP fragment, GFP1-10, is encoded in the mitochondrial genome and the shorter one, GFP11, is C-terminally attached to every protein encoded in the genome of yeast Saccharomyces cerevisiae. GFP fluorescence can therefore only be reconstituted if the C-terminus of the protein is present in the mitochondrial matrix, either as part of a soluble protein, a peripheral membrane protein, or an integral inner membrane protein. The system, combined with high-throughput fluorescence microscopy of yeast cells grown under six different conditions, enabled the authors to visualize ca. 400 mitochondrial proteins, 50 of which were not visualised before and 8 of which were not shown to be mitochondrial before. The system appears to be particularly well suited for analysis of dually localized proteins and could potentially be used to study sorting pathways of mitochondrial inner membrane proteins.

Strengths:

Many fluorescence-based genome-wide screens were previously performed in yeast and were central to revealing the subcellular location of a large fraction of yeast proteome. Nonetheless, these screens also showed that tagging with full-length fluorescent proteins (FP) can affect both the function and targeting of proteins. The strength of the system used in the current manuscript is that the shorter tag is beneficial for the detection of a number of proteins whose targeting and/or function is affected by tagging with full-length FPs.

Furthermore, the system used here can nicely detect mitochondrial pools of dually localized proteins. It is especially useful when these pools are minor and their signals are therefore easily masked by the strong signals coming from the major, nonmitochondrial pools of the proteins.

Weaknesses:

My only concern is that the biological significance of the screen performed appears limited. The dataset obtained is largely in agreement with several previous proteomic screens but it is, unfortunately, not more comprehensive than them, rather the opposite. For proteins that were identified inside mitochondria for the first time here or were identified in an unexpected location within the organelle, it remains unclear whether these localizations represent some minor, missorted pools of proteins or are indeed functionally important fractions and/or productive translocation intermediates. The authors also allude to several potential applications of the system but do little to explore any of these directions.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation